首页> 外文期刊>European journal of ophthalmology >Standard and accelerated corneal cross-linking long-term results: A randomized clinical trial
【24h】

Standard and accelerated corneal cross-linking long-term results: A randomized clinical trial

机译:标准和加速角膜交联长期结果:随机临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To compare long-term results between accelerated and standard corneal cross-linking protocols in the treatment of progressive keratoconus and compare their effectiveness between central (cone in the central 3 mm) and peripheral (cone beyond 3 mm) cases. Methods: In this randomized clinical trial, we compared 31 eyes treated with accelerated corneal cross-linking (18 mW/cm(2), 5 min) and 31 eyes treated with standard corneal cross-linking (3 mW/cm(2), 30 min), 16 central and 11 peripheral keratoconus in each group. In this report, 4-year changes in vision, refraction, topography, corneal biomechanics, and corneal cell count were evaluated. Results: Uncorrected distance visual acuity improvement was better with standard corneal cross-linking (0.19 +/- 0.30 logMAR) than accelerated corneal cross-linking (0.08 +/- 0.35 logMAR), but the intergroup difference was not statistically significant (p = 0.283). Cylinder and spherical equivalent significantly increased similarly in both groups. Among topographic indices, anterior Kmax-3 mm showed more reduction in standard corneal cross-linking than accelerated corneal cross-linking (1.35 +/- 1.39 vs 0.36 +/- 1.10 D, p = 0.011). Anterior Kmax-8 mm reduced by 1.50 +/- 1.82 and 0.37 +/- 1.58 D in the standard corneal cross-linking and accelerated corneal cross-linking groups, respectively (p = 0.029). Compared to 18-month results, none of the indices at 4 years showed any significant intergroup difference (all p > 0.05). In cases with peripheral keratoconus, changes in anterior Kmax-3 mm (+0.03 +/- 0.66 vs -1.17 +/- 1.15 D, p = 0.012) and anterior Kmax-8 mm (+0.43 +/- 1.09 vs -1.57 +/- 1.40 D, p = 0.003) were greater with standard corneal cross-linking. In central cases, no significant intergroup difference was observed. Conclusion: At 4 years after the procedure, standard corneal cross-linking offered better anterior corneal flattening in the center and periphery. These differences concerned cases of peripheral keratoconus, and the two protocols were similarly effective in central cases. Beyond the 18th month, the two protocols appeared to be similarly effective.
机译:目的:比较加速和标准角膜交联方案之间的长期结果,治疗渐进式角蛋白酶,并比较中央(中央3mm的锥体)与外周(锥体超过3mm)的效果。方法:在该随机临床试验中,我们将31只眼睛与加速的角膜交联(18mW / cm(2),5分钟)和31只眼睛进行了比较,用标准角膜交联(3mW / cm(2),每组30分钟),16个中央和11个外周角蛋白。在本报告中,评估了4年的视觉,折射,地形,角膜生物力学和角膜细胞计数的变化。结果:未经校正的距离视力改善与标准角膜交联(0.19 +/- 0.30 logmar)更好,而不是加速角膜交联(0.08 +/- 0.35 Logmar),但互连差异没有统计学意义(P = 0.283 )。两组中,气缸和球形等同物显着增加。在地形指数中,前kmax-3 mm的标准角膜交联比加速角膜交联(1.35 +/- 1.39 Vs 0.36 +/- 1.10d,p = 0.011)显示出更多的标准角膜交联。在标准角膜交联和加速角膜交联组中,前kmax-8 mm减少1.50 +/- 1.82和0.37 +/- 1.58d(p = 0.029)。与18个月的结果相比,4年的指数都没有显示出任何显着的互动差异(所有P> 0.05)。在外周角质管的情况下,前kmax-3 mm的变化(+0.03 +/- 0.66 Vs -1.17 +/- 1.15d,p = 0.012)和前ymax-8 mm(+0.43 +/- 1.09 Vs -1.57 + / - 1.40d,p = 0.003)较大,具有标准的角膜交联。在中央病例中,没有观察到显着的互动差异。结论:在手术后4年,标准的角膜交联在中心和周边提供了更好的前角膜扁平化。这些差异有关周围角蛋白的病例,以及两种方案在中央案件中同样有效。在第18个月之后,这两种协议似乎类似地有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号